JP2011507855A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011507855A5 JP2011507855A5 JP2010539511A JP2010539511A JP2011507855A5 JP 2011507855 A5 JP2011507855 A5 JP 2011507855A5 JP 2010539511 A JP2010539511 A JP 2010539511A JP 2010539511 A JP2010539511 A JP 2010539511A JP 2011507855 A5 JP2011507855 A5 JP 2011507855A5
- Authority
- JP
- Japan
- Prior art keywords
- connexin
- composition
- agent
- polynucleotide
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US888807P | 2007-12-21 | 2007-12-21 | |
| PCT/US2008/014019 WO2009085268A2 (en) | 2007-12-21 | 2008-12-22 | Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of surgical adhesions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014152828A Division JP2014208699A (ja) | 2007-12-21 | 2014-07-28 | 外科的癒着の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた抗コネキシンペプチドの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011507855A JP2011507855A (ja) | 2011-03-10 |
| JP2011507855A5 true JP2011507855A5 (enExample) | 2013-04-25 |
Family
ID=40824953
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010539511A Pending JP2011507855A (ja) | 2007-12-21 | 2008-12-22 | 外科的癒着の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた抗コネキシンペプチドの使用 |
| JP2014152828A Pending JP2014208699A (ja) | 2007-12-21 | 2014-07-28 | 外科的癒着の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた抗コネキシンペプチドの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014152828A Pending JP2014208699A (ja) | 2007-12-21 | 2014-07-28 | 外科的癒着の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた抗コネキシンペプチドの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110245184A1 (enExample) |
| EP (1) | EP2237796A2 (enExample) |
| JP (2) | JP2011507855A (enExample) |
| AU (1) | AU2008343839A1 (enExample) |
| CA (1) | CA2710223A1 (enExample) |
| WO (1) | WO2009085268A2 (enExample) |
| ZA (1) | ZA201005215B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2662088A3 (en) | 2005-02-03 | 2014-02-19 | Coda Therapeutics Limited | Anti-connexin compounds and uses thereof |
| AU2008335718A1 (en) * | 2007-12-11 | 2009-06-18 | Coda Therapeutics, Inc. | Impaired wound healing compositions and treatments |
| US8975237B2 (en) | 2007-12-21 | 2015-03-10 | Coda Therapeutics, Inc. | Treatment of fibrotic conditions |
| CN104271142B (zh) | 2012-03-01 | 2017-07-04 | 福斯特斯特林研究公司 | 含有α连接蛋白C‑末端(ACT)肽的局部凝胶 |
| US9156896B2 (en) | 2013-03-15 | 2015-10-13 | Coda Therapeutics, Inc. | Wound healing compositions and treatments |
| WO2015139047A2 (en) * | 2014-03-14 | 2015-09-17 | Coda Therapeutics | Treatment of resistant lesions |
| JP6683686B2 (ja) | 2014-08-22 | 2020-04-22 | オークランド ユニサービシーズ リミティド | チャネル調節剤 |
| CN105566495B (zh) * | 2016-01-27 | 2019-10-22 | 上海科技大学 | 一种特异性抑制连接蛋白26的全人抗体 |
| WO2018199777A1 (en) | 2017-04-28 | 2018-11-01 | Auckland Uniservices Limited | Methods of treatment and novel constructs |
| EP4232157A4 (en) | 2020-10-22 | 2024-08-28 | Xequel Bio, Inc. | PEPTIDE FORMULATIONS AND ASSOCIATED OPHTHALMIC USES |
| JP6911993B1 (ja) * | 2020-12-11 | 2021-07-28 | 東洋インキＳｃホールディングス株式会社 | 抗菌性活性エネルギー線硬化型コーティング組成物、コーティング層、抗菌性部材、および物品 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2361251C (en) * | 1999-01-27 | 2011-03-08 | David L. Becker | Formulations comprising antisense nucleotides to connexins |
| JP2005509621A (ja) * | 2001-10-17 | 2005-04-14 | ユニバーシティ オブ ウェールズ カレッジ オブ メディスン | ギャップ結合ならびにｅｄｈｆ |
| WO2006006948A2 (en) * | 2002-11-14 | 2006-01-19 | Dharmacon, Inc. | METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY |
| HUE038099T2 (hu) * | 2004-12-21 | 2018-09-28 | Musc Found For Res Dev | Kompozíciók és módszerek sebgyógyulás és szöveti regeneráció elõsegítésére |
| EP2662088A3 (en) * | 2005-02-03 | 2014-02-19 | Coda Therapeutics Limited | Anti-connexin compounds and uses thereof |
| JP5960944B2 (ja) * | 2006-11-15 | 2016-08-02 | コーダ セラピューティクス， インコーポレイテッド | 創傷治癒のための改善された方法および組成物 |
| AU2008335718A1 (en) * | 2007-12-11 | 2009-06-18 | Coda Therapeutics, Inc. | Impaired wound healing compositions and treatments |
| CA2709151A1 (en) * | 2007-12-11 | 2009-06-18 | Coda Therapeutics, Inc. | Impaired wound healing compositions and treatments |
-
2008
- 2008-12-22 AU AU2008343839A patent/AU2008343839A1/en not_active Abandoned
- 2008-12-22 US US12/809,989 patent/US20110245184A1/en not_active Abandoned
- 2008-12-22 EP EP08868841A patent/EP2237796A2/en not_active Ceased
- 2008-12-22 JP JP2010539511A patent/JP2011507855A/ja active Pending
- 2008-12-22 WO PCT/US2008/014019 patent/WO2009085268A2/en not_active Ceased
- 2008-12-22 CA CA2710223A patent/CA2710223A1/en not_active Abandoned
-
2010
- 2010-07-21 ZA ZA2010/05215A patent/ZA201005215B/en unknown
-
2014
- 2014-07-28 JP JP2014152828A patent/JP2014208699A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011507861A5 (enExample) | ||
| JP2011507860A5 (enExample) | ||
| JP5185826B2 (ja) | ウイルス性肝炎の処置 | |
| JP2021091690A (ja) | 急性骨髄性白血病（ａｍｌ）のための新規併用治療 | |
| US10335455B2 (en) | Method for prevention or treatment of intractable inflammatory bowel disease | |
| JP2009522371A5 (enExample) | ||
| EA032767B1 (ru) | Применение баклофена или его соли для лечения болезни шарко-мари-тусса (смт) и связанного с ней расстройства | |
| EA024523B1 (ru) | Фармацевтическая композиция для лечения болезни шарко-мари-тута и родственных с ней расстройств | |
| TW202304424A (zh) | 包含依維莫司和安森司群的組合 | |
| JP2018087228A (ja) | がんのためのグルフォスファミド組み合わせ療法 | |
| JP2009544585A5 (enExample) | ||
| KR20120014251A (ko) | 동종이식편의 접합을 개선하기 위한 생체활성 코팅 조성물 및 방법 | |
| EP4499122A2 (en) | Rna comprising secretomes and methods of their use | |
| KR101628448B1 (ko) | 암 치료에 사용하기 위한 베무라페닙 및 인터페론을 포함하는 병용 요법 | |
| JP2021510731A (ja) | ペプチドおよびその使用 | |
| JP2011507859A5 (enExample) | ||
| AU2008335840A1 (en) | Treatment of melanoma with alpha thymosin peptides in combination with antibodies against cytotoxic T lymphocyte-associated antigen 4 (CTLA4) | |
| Bufalari et al. | Preemptive carprofen for peri-operative analgesia in dogs undergoing Tibial Plateau Leveling Osteotomy (TPLO): a prospective, randomized, blinded, placebo controlled clinical trial | |
| US9107893B2 (en) | Methods, pharmaceutical compositions and kits for use in the treatment of adult T-cell leukemia/lymphoma | |
| AU782357B2 (en) | Treatment of dyskinesia | |
| WO2016071431A9 (en) | A combination for cancer therapy | |
| WO2007139433A8 (en) | Peptide substance normalizing the metabolism in osseous and cartilaginous tissues, pharmaceutical composition on its base and the method of its application | |
| US9173918B2 (en) | Compositions and methods for the treatment of cardiac surgery-associated acute kidney injury with annexin A1 peptide | |
| US20130102662A1 (en) | Use of inducible nitric oxide synthase inhibitors and nitric oxide scavengers to inhibit post-traumatic immunodepression | |
| JP2026507878A (ja) | 膵臓癌の処置のための複合薬 |